| Literature DB >> 16154858 |
Monica Tani, Mariapaola Fina, Lapo Alinari, Vittorio Stefoni, Michele Baccarani, Pier Luigi Zinzani.
Abstract
Between July 2003 and March 2004, nine patients with pretreated mycosis fungoides were enrolled into a phase II trial and were treated with temozolomide. The overall response rate was 33%. Further studies are needed to test the efficacy of temozolomide, alone or in combination in earlier stages of this disease.Entities:
Mesh：
Substances：
Year: 2005 PMID： 16154858
Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941